Literature DB >> 22801951

Glomerular disease: Predicting outcomes in idiopathic membranous nephropathy.

Manuel Praga1, Jorge Rojas-Rivera.   

Abstract

Several immunosuppressive treatments have demonstrated their efficacy in idiopathic membranous nephropathy, but spontaneous remission does develop in more than 30% of patients. The availability of a validated biomarker that is easy to measure and able to accurately predict long-term outcomes would be very helpful for tailoring treatment of the disease to the individual.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801951     DOI: 10.1038/nrneph.2012.161

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  10 in total

1.  Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.

Authors:  Jan A J G van den Brand; Julia M Hofstra; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 8.237

2.  Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy.

Authors:  Natalia Polanco; Elena Gutiérrez; Adelardo Covarsí; Francisco Ariza; Agustín Carreño; Ana Vigil; José Baltar; Gema Fernández-Fresnedo; Carmen Martín; Salvador Pons; Dolores Lorenzo; Carmen Bernis; Pilar Arrizabalaga; Gema Fernández-Juárez; Vicente Barrio; Milagros Sierra; Ines Castellanos; Mario Espinosa; Francisco Rivera; Aniana Oliet; Francisco Fernández-Vega; Manuel Praga
Journal:  J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 10.121

Review 3.  Membranous nephropathy: recent travels and new roads ahead.

Authors:  Laurence H Beck; David J Salant
Journal:  Kidney Int       Date:  2010-02-24       Impact factor: 10.612

4.  Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy.

Authors:  Jan A J G van den Brand; Julia M Hofstra; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

5.  Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications.

Authors:  D C Cattran; Y Pei; C M Greenwood; C Ponticelli; P Passerini; E Honkanen
Journal:  Kidney Int       Date:  1997-03       Impact factor: 10.612

6.  Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study.

Authors:  Amanda J W Branten; Peggy W du Buf-Vereijken; Ina S Klasen; Frank H Bosch; Geert W Feith; Daan A Hollander; Jack F Wetzels
Journal:  J Am Soc Nephrol       Date:  2004-11-24       Impact factor: 10.121

Review 7.  Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.

Authors:  Peggy W G du Buf-Vereijken; Amanda J W Branten; Jack F M Wetzels
Journal:  Am J Kidney Dis       Date:  2005-12       Impact factor: 8.860

8.  Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.

Authors:  Laurence H Beck; Fernando C Fervenza; David M Beck; Ramon G B Bonegio; Fahim A Malik; Stephen B Erickson; Fernando G Cosio; Daniel C Cattran; David J Salant
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

9.  Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Laurence H Beck; David M Beck; Jack F Wetzels; David J Salant
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-07       Impact factor: 8.237

10.  Idiopathic membranous nephropathy: diagnosis and treatment.

Authors:  Fernando C Fervenza; Sanjeev Sethi; Ulrich Specks
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

  10 in total
  4 in total

Review 1.  Treatment of idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Fernando C Fervenza; Jack F M Wetzels
Journal:  Nat Rev Nephrol       Date:  2013-07-02       Impact factor: 28.314

2.  The clinicopathological features of patients with membranous nephropathy.

Authors:  Hanyu Zhu; Qiuxia Han; Dong Zhang; Yong Wang; Jing Gao; Xiaoli Yang; Wenjia Geng; Xiangmei Chen
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-01-18

3.  Integrated profiling of microRNA expression in membranous nephropathy using high-throughput sequencing technology.

Authors:  Wenbiao Chen; Xiaocong Lin; Jianrong Huang; Kuibi Tan; Yuyu Chen; Wujian Peng; Wuxian Li; Yong Dai
Journal:  Int J Mol Med       Date:  2013-11-12       Impact factor: 4.101

4.  miR-217 Is a Useful Diagnostic Biomarker and Regulates Human Podocyte Cells Apoptosis via Targeting TNFSF11 in Membranous Nephropathy.

Authors:  Jing Li; Bin Liu; Hen Xue; Qiao Qiao Zhou; Ling Peng
Journal:  Biomed Res Int       Date:  2017-10-30       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.